Inovio Pharmaceuticals, Inc. SEC filings INO
Inovio Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 20, 2008. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 7, 2026 | May 20, 2026 |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 20, 2025 |
| DEF 14A | Proxy statement | Apr 11, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Nov 28, 2023 | Jan 12, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2023 | Jan 12, 2024 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 11, 2022 | — |
| DEF 14A | Proxy statement | Mar 25, 2022 | May 16, 2022 |
| DEF 14A | Proxy statement | Mar 25, 2021 | Dec 31, 2020 |
| DEFA14A | Additional proxy material | Apr 15, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | Dec 31, 2019 |
| DEF 14A | Proxy statement | Mar 25, 2019 | Dec 31, 2018 |
| DEF 14A | Proxy statement | Mar 28, 2018 | May 11, 2018 |
| DEF 14A | Proxy statement | Mar 29, 2017 | Mar 17, 2017 |
| DEF 14A | Proxy statement | Mar 25, 2016 | Mar 25, 2016 |
| DEF 14A | Proxy statement | Mar 20, 2015 | May 8, 2015 |
| DEF 14A | Proxy statement | Apr 7, 2014 | May 22, 2014 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2014 | May 22, 2014 |
| DEF 14A | Proxy statement | Mar 29, 2013 | May 17, 2013 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2013 | May 17, 2013 |
| DEF 14A | Proxy statement | Apr 6, 2012 | May 16, 2012 |
| DEF 14A | Proxy statement | Apr 12, 2011 | May 13, 2011 |
| DEF 14A | Proxy statement | Apr 12, 2010 | May 14, 2010 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2010 | May 14, 2010 |
| DEF 14A | Proxy statement | Jul 10, 2009 | Aug 25, 2009 |
| DEF 14A | Proxy statement | Apr 1, 2008 | May 2, 2008 |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP (until May 11, 2010); GENETRONICS BIOMEDICAL CORP (until Apr 1, 2005); GENETRONICS BIOMEDICAL LTD (until Aug 3, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.